[Wiley] Efficacy and Safety of Durvalumab Plus Tremelimumab in Hepatocellular Carcinoma Patients With Portal Vein Thrombosis and High Tumor Burden: A Multicenter Retrospective Analysis

noona Post time 3 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-28 15:34
Reward10points

journalㄩHepatology Research

AuthorsㄩTakeshi Hatanaka; Yutaka Yata; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Satoru Kakizaki; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hidenori Toyoda; Yuichi Koshiyama; Chikara Ogawa; Hiroki Nishikawa; Takashi Nishimura; Kazuhito Kawata; Hisashi Kosaka; Kosuke Matsui; Atsushi Naganuma; Hironori Tanaka; Hideko Ohama; Hidekatsu Kuroda; Tomomitsu Matono; Tomoko Aoki; Hironori Ochi; Michitaka Imai; Shinichiro Nakamura; Shohei Komatsu; Hideyuki Tamai; Jumpei Okamura; Yuki Kanayama; Kazunari Tanaka; Fujimasa Tada; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Takanori Matsuura; Hidenao Noritake; Hirayuki Enomoto; Masaki Kaibori; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada;  

Published dateㄩ2026-1-

DOIㄩ10.1111/hepr.70033

PDF linkㄩhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hepr.70033

Article linkㄩhttps://doi.org/10.1111/hepr.70033

Article SourceㄩWiley


Remarkㄩ
Reply

Use magic Donate Report

All Reply1 Show all posts
Victor90 Post time 3 day(s) ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Return to the list